Joint Filing AgreementJoint Filing Agreement • February 14th, 2020 • Biotechnology Value Fund L P • Investment advice
Contract Type FiledFebruary 14th, 2020 Company IndustryThe undersigned hereby agree that the Statement on Schedule 13G dated February 14, 2020 with respect to the shares of Common Stock of Xenon Pharmaceuticals Inc., and any further amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.